• Something wrong with this record ?

Cost-effectiveness of care for people with psychosis in the community and psychiatric hospitals in the Czech Republic: an economic analysis

P. Winkler, L. Koeser, L. Kondrátová, HM. Broulíková, M. Páv, L. Kališová, B. Barrett, P. McCrone,

. 2018 ; 5 (12) : 1023-1031. [pub] 20181108

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19045146

BACKGROUND: The absence of economic evidence hinders current reforms of hospital-based mental health systems in central and eastern Europe. We aimed to assess the cost-effectiveness of discharge to community care for people with chronic psychoses compared with care in psychiatric hospitals in the Czech Republic. METHODS: We did a prospective study of people aged 18-64 years with chronic psychotic disorders in the Czech Republic who had been discharged into community services or were receiving inpatient psychiatric care for at least 3 months at baseline. We measured health-related quality of life with the EuroQol five-dimension five-level questionnaire. Adjusting for baseline differences between the two groups, we assessed differences in societal costs in 2016 and quality-adjusted life-years (QALYs) during a 12-month follow-up, which we then used to estimate the incremental cost-effectiveness ratio (ICER). We did multiple sensitivity analyses to assess the robustness of our results. FINDINGS: In our baseline case scenario, we included 115 patients who were either community service users (n=35) or inpatients (n=80) at baseline. The two groups were similar in terms of baseline characteristics. The annual QALY was 0·77 in patients receiving community care at baseline compared with 0·80 in patients in hospital at baseline (difference 0·03, 95% CI -0·04 to 0·10), but the costs of discharge to the community were €8503 compared with €16 425 for no discharge (difference €7922, 95% CI 4497-11 346), such that the ICER reached more than €250 000 per QALY. This ICER is substantially higher than levels that are conventionally considered to be cost-effective and the estimated probability that discharge to the community was cost-effective was very high (≥97%). None of the sensitivity analyses changed these results qualitatively. INTERPRETATION: This study provides economic evidence for deinstitutionalisation by showing that discharge to community care is cost-effective compared with care in psychiatric hospitals in the Czech Republic. These findings add to the human rights and clinical-based arguments for mental health-care reforms in central and eastern Europe. FUNDING: Ministry of Education, Youth and Sports of the Czech Republic; EEA and Norway Grants.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045146
003      
CZ-PrNML
005      
20200120101221.0
007      
ta
008      
200109s2018 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/S2215-0366(18)30388-2 $2 doi
035    __
$a (PubMed)30415938
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Winkler, Petr $u Department of Social Psychiatry, National Institute of Mental Health, Klecany, Czech Republic; Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK. Electronic address: petr.winkler@nudz.cz.
245    10
$a Cost-effectiveness of care for people with psychosis in the community and psychiatric hospitals in the Czech Republic: an economic analysis / $c P. Winkler, L. Koeser, L. Kondrátová, HM. Broulíková, M. Páv, L. Kališová, B. Barrett, P. McCrone,
520    9_
$a BACKGROUND: The absence of economic evidence hinders current reforms of hospital-based mental health systems in central and eastern Europe. We aimed to assess the cost-effectiveness of discharge to community care for people with chronic psychoses compared with care in psychiatric hospitals in the Czech Republic. METHODS: We did a prospective study of people aged 18-64 years with chronic psychotic disorders in the Czech Republic who had been discharged into community services or were receiving inpatient psychiatric care for at least 3 months at baseline. We measured health-related quality of life with the EuroQol five-dimension five-level questionnaire. Adjusting for baseline differences between the two groups, we assessed differences in societal costs in 2016 and quality-adjusted life-years (QALYs) during a 12-month follow-up, which we then used to estimate the incremental cost-effectiveness ratio (ICER). We did multiple sensitivity analyses to assess the robustness of our results. FINDINGS: In our baseline case scenario, we included 115 patients who were either community service users (n=35) or inpatients (n=80) at baseline. The two groups were similar in terms of baseline characteristics. The annual QALY was 0·77 in patients receiving community care at baseline compared with 0·80 in patients in hospital at baseline (difference 0·03, 95% CI -0·04 to 0·10), but the costs of discharge to the community were €8503 compared with €16 425 for no discharge (difference €7922, 95% CI 4497-11 346), such that the ICER reached more than €250 000 per QALY. This ICER is substantially higher than levels that are conventionally considered to be cost-effective and the estimated probability that discharge to the community was cost-effective was very high (≥97%). None of the sensitivity analyses changed these results qualitatively. INTERPRETATION: This study provides economic evidence for deinstitutionalisation by showing that discharge to community care is cost-effective compared with care in psychiatric hospitals in the Czech Republic. These findings add to the human rights and clinical-based arguments for mental health-care reforms in central and eastern Europe. FUNDING: Ministry of Education, Youth and Sports of the Czech Republic; EEA and Norway Grants.
650    _2
$a dospělí $7 D000328
650    _2
$a služby v oblasti duševního zdraví komunity $x ekonomika $x statistika a číselné údaje $7 D003156
650    12
$a analýza nákladů a výnosů $7 D003362
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a ústavy pro duševně nemocné $x ekonomika $x statistika a číselné údaje $7 D006778
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a psychotické poruchy $x terapie $7 D011618
650    _2
$a kvalitativně upravené roky života $7 D019057
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Koeser, Leonardo $u Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
700    1_
$a Kondrátová, Lucie $u Department of Social Psychiatry, National Institute of Mental Health, Klecany, Czech Republic.
700    1_
$a Broulíková, Hana Marie $u Department of Social Psychiatry, National Institute of Mental Health, Klecany, Czech Republic; Faculty of Informatics and Statistics, University of Economics, Prague, Czech Republic.
700    1_
$a Páv, Marek $u Psychiatric Clinic, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kališová, Lucie $u Psychiatric Clinic, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Barrett, Barbara $u Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
700    1_
$a McCrone, Paul $u Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
773    0_
$w MED00193477 $t The lancet. Psychiatry $x 2215-0374 $g Roč. 5, č. 12 (2018), s. 1023-1031
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30415938 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200120101558 $b ABA008
999    __
$a ok $b bmc $g 1483415 $s 1083819
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 5 $c 12 $d 1023-1031 $e 20181108 $i 2215-0374 $m The Lancet. Psychiatry $n Lancet Psychiatry $x MED00193477
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Archiving options